The latest signs of the consumer health product sector’s interest in driving sales through marketing to consumers using GLP-1 drugs for weight loss suggest the size of the opportunity.
That’s because the latest plays related to selling to consumers using glucagon-like peptide-1 receptor agonist drugs indicated for type 2...




